Amgen Initiates Voluntary Nationwide Recall Of Certain Lots Of Epogen® And Procrit® (Epoetin Alfa)

September 28, 2010
By JONES WARD PLC on September 28, 2010 7:08 PM |

Amgen (NASDAQ: AMGN) announced on Friday that certain lots of EPOGEN® and PROCRIT® vials are being voluntarily recalled because they may contain extremely thin glass flakes (lamellae) that are barely visible in most cases.

Posted by Louisville, Kentucky lawyer Larry Jones. Larry can be reached at larry@jonesward.com or by using his toll-free number 1-888-KYLAW22.